乙型肝炎表面抗原清除后肝细胞癌的风险预测模型
该研究回顾性纳入831例实现乙型肝炎表面抗原(HBsAg)清除的慢性乙型肝炎患者,随访4,644人年,40例(4.8%)发生肝细胞癌(HCC),年发生率0.86%。基于HBsAg清除时年龄、肝硬化、HCC家族史和超过中等量饮酒构建的预测模型C指数为0.804,5、10、15年时间依赖AUROC分别为0.799、0.835、0.817,内部验证区分度良好。
要点
- HBsAg清除后HCC年发生率为0.86%,仍需风险分层管理。
- HBsAg清除时年龄、肝硬化、HCC家族史和超过中等量饮酒是HCC独立预测因素。
- 基于4个变量的预测模型C指数0.804,5、10、15年AUROC分别为0.799、0.835、0.817。
核心结论
- 基于年龄、肝硬化、HCC家族史和饮酒的新型预测模型可对HBsAg清除后HCC进行可靠风险估计,或可为HBsAg清除患者的HCC监测决策提供参考。
研究设计与样本
- 回顾性筛查1991年至2020年间实现HBsAg清除的1,443例慢性乙型肝炎患者,最终纳入831例进行分析。
- 基于多变量Cox模型开发预测模型,采用Harrell C指数和时间依赖AUROC评估区分度,Bootstrap分析进行内部验证。
主要发现
- 中位随访4,644人年期间,40例(4.8%)在HBsAg清除后发生HCC,年发生率为0.86%。
- HBsAg清除时年龄、肝硬化存在、HCC家族史和超过中等量饮酒为HCC的独立预测因素。
- 模型C指数为0.804,5年、10年和15年HCC预测的时间依赖AUROC分别为0.799、0.835和0.817。
- 模型在内部验证和敏感性分析中均显示出良好区分度。
关键数值与推荐
- 预测模型包含4个变量:HBsAg清除时年龄、肝硬化、HCC家族史和超过中等量饮酒。
- 模型区分度:C指数0.804;5年、10年、15年时间依赖AUROC分别为0.799、0.835、0.817。
临床怎么用
- 原文结论认为该模型或可作为HBsAg清除患者HCC监测决策的参考,未给出具体推荐等级。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: After hepatitis B surface antigen (HBsAg) seroclearance, the risk of hepatocellular carcinoma (HCC) remains, and the optimal surveillance strategy has yet to be determined. Herein, we aimed to evaluate incidence and risk factors for HCC and establish a novel prediction model for HCC development after HBsAg seroclearance. METHODS: A total of 1,443 patients with chronic hepatitis B who achieved HBsAg seroclearance between 1991 and 2020 were retrospectively screened for study eligibility. The data from 831 of these patients were included in the final analysis. A prediction model was developed based on multivariable Cox models. Harrell's C-index and a time-dependent AUROC were used for discrimination. Bootstrap analysis was performed for internal validation. RESULTS: Overall, 40 patients (4.8%) developed HCC after HBsAg seroclearance during a follow-up of 4,644 person-years (0.86%/year). Age at HBsAg seroclearance, presence of cirrhosis, family history of HCC, and more-than-moderate alcohol consumption were independently predictive of HCC, and these 4 independent variables were used to develop the prediction model. The C-index of the model was 0.804. The time-dependent AUROCs of the score for HCC prediction at 5, 10, and 15 years were 0.799, 0.835, and 0.817, respectively. The score also showed good discrimination in the internal validation and sensitivity analysis. CONCLUSIONS: The novel prediction model based on age, cirrhosis, family history of HCC, and alcohol consumption enables reliable risk estimation of HCC after HBsAg seroclearance and may serve as a useful reference for decision-making in HCC surveillance for HBsAg-cleared patients. LAY SUMMARY: After spontaneous hepatitis B surface antigen (HBsAg) seroclearance, the risk of hepatocellular carcinoma (HCC) remains. Age at HBsAg seroclearance, presence of cirrhosis, family history of HCC, and more-than-moderate alcohol consumption were independently associated with HCC development after HBsAg seroclearance. The novel prediction model using these 4 variables enables reliable risk estimation of HCC and serves as a useful reference for decision-making in HCC surveillance and management for HBsAg-cleared patients.
引用
- Yang H, Bae SH, Nam H, et al. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2022. PMID: 35398462. doi:10.1016/j.jhep.2022.03.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。